Biopharmaceutical benchmarks 2022

Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.

Detalles Bibliográficos
Autores principales: Walsh, Gary, Walsh, Eithne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735008/
https://www.ncbi.nlm.nih.gov/pubmed/36471135
http://dx.doi.org/10.1038/s41587-022-01582-x
_version_ 1784846678595993600
author Walsh, Gary
Walsh, Eithne
author_facet Walsh, Gary
Walsh, Eithne
author_sort Walsh, Gary
collection PubMed
description Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.
format Online
Article
Text
id pubmed-9735008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-97350082022-12-12 Biopharmaceutical benchmarks 2022 Walsh, Gary Walsh, Eithne Nat Biotechnol Feature Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products. Nature Publishing Group US 2022-12-05 2022 /pmc/articles/PMC9735008/ /pubmed/36471135 http://dx.doi.org/10.1038/s41587-022-01582-x Text en © The Author(s), under exclusive licence to Springer Nature America, Inc. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Feature
Walsh, Gary
Walsh, Eithne
Biopharmaceutical benchmarks 2022
title Biopharmaceutical benchmarks 2022
title_full Biopharmaceutical benchmarks 2022
title_fullStr Biopharmaceutical benchmarks 2022
title_full_unstemmed Biopharmaceutical benchmarks 2022
title_short Biopharmaceutical benchmarks 2022
title_sort biopharmaceutical benchmarks 2022
topic Feature
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735008/
https://www.ncbi.nlm.nih.gov/pubmed/36471135
http://dx.doi.org/10.1038/s41587-022-01582-x
work_keys_str_mv AT walshgary biopharmaceuticalbenchmarks2022
AT walsheithne biopharmaceuticalbenchmarks2022

Ejemplares similares